Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patientsAbi Vijenthira, Lisa K. Hicks, Inna Y. Gong et al.|Blood|2020Cited by 657
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patientsWilma Barcellini, Alberto Zanella, Bruno Fattizzo et al.|Blood|2014Cited by 371
Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic AnemiaWilma Barcellini, Bruno Fattizzo|Disease Markers|2015Cited by 281
Cold agglutinin disease revisited: a multinational, observational study of 232 patientsSigbjørn Berentsen, Geir E. Tjønnfjord, Hege Frøen et al.|Blood|2020Cited by 167
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studiesWilma Barcellini, Alberto Zanella, Francesco Zaja et al.|Blood|2012Cited by 144